0000000000205856

AUTHOR

Tatjana Tracevska

showing 5 related works from this author

Phenotypic and genetic analysis of biofilm formation by Staphylococcus epidermidis.

2012

Objective. The most important virulence factor of Staphylococcus epidermidis is their capability to form a biofilm on the surfaces of implanted medical devices. The accumulative phase of biofilm formation is linked to the production of intercellular adhesin encoded by the icaADBC operon and accumulation-associated protein by the aap gene. The aim of the study was to investigate biofilm formation phenotypically and genetically in clinical strains of S. epidermidis in comparison with commensal strains. Material and Methods. The study was carried out in 4 hospitals in Riga, Latvia. In total, 105 clinical strains of Staphylococcus epidermidis isolated from patients’ blood (n=67) and intravenous…

AdultMaleOperonVirulenceVirulence factorlaw.inventionMicrobiologylawStaphylococcus epidermidisOperonStaphylococcus epidermidisMedicineHumansPolymerase chain reactionAgedAged 80 and overCross InfectionbiologyVirulencebusiness.industryBiofilmGeneral MedicineMiddle AgedStaphylococcal Infectionsbiology.organism_classificationmedicine.diseaseBacterial adhesin<em>Staphylococcus epidermidis</em>; nosocomial infections; biofilm formation; virulence factorsGenes BacterialBacteremiaBiofilmsFemalebusinessMedicina (Kaunas, Lithuania)
researchProduct

Prevalence of Extended Spectrum Beta Lactamase Producing Bacteria in Two Surgical Wards of a General Hospital

2019

Abstract Colonisation of gastrointestinal tract by extended spectrum beta lactamase (ESBL)-producing Gram-negative bacteria is a source for infections. The present work is a prospective study in Latvia aimed to determine the role of two surgical profile wards in transmission of ESBL-producing bacteria. Differences between hospital wards were not analysed due to low number of patients. We have also determined a correlation between the duration of hospitalisation and risk of ESBL colonisation. Tests for ESBL-producing bacteria were made twice for 136 patients — upon admission and upon discharge from the hospital. Of them, 21 (15.4%) patients already were ESBL-positive at the time of admission…

0301 basic medicineesblMultidisciplinarybiologygut microbiotabusiness.industrymedicine.medical_treatmentScience030106 microbiologyQbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesMicrobiology03 medical and health sciences0302 clinical medicineBeta-lactamasemedicinepolycyclic compoundsbacteria030212 general & internal medicineGeneral hospitalbusinessBacteriabacterial colonisationProceedings of the Latvian Academy of Sciences. Section B, Natural Sciences
researchProduct

Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis.

2003

In order to characterise molecular mechanisms of first-line drug resistance in Mycobacterium tuberculosis and to evaluate the use of molecular markers of resistance (gene point mutations), we analysed 66 multi-drug-resistant (MDR) isolates from Latvian tuberculosis patients. They were all resistant to rifampin (RIF), isoniazid (INH) and streptomycin (SM), and 33 were resistant to ethambutol (EMB). Enzymatic digestion by MboII and nucleotide sequencing of the rpsL gene fragment detected a single nucleotide substitution K43R in 40 (61%) of the 66 SM-resistant M. tuberculosis isolates. Of the other 26 SM-resistant isolates, 16 (24%) had mutations at positions 513A--C and 516C--T of the rrs gen…

DNA BacterialRibosomal ProteinsDrug resistanceGene mutationMicrobiologyPolymerase Chain ReactionMycobacterium tuberculosisAnti-Infective AgentsDrug Resistance Multiple BacterialRNA Ribosomal 16SmedicineHumansTuberculosisDeoxyribonucleases Type II Site-SpecificMolecular BiologyEthambutolPolymorphism Single-Stranded ConformationalAntibacterial agentGeneticsbiologyPoint mutationSingle-strand conformation polymorphismGeneral MedicineMycobacterium tuberculosisSequence Analysis DNAbiology.organism_classificationMolecular biologyStreptomycinStreptomycinEthambutolmedicine.drugResearch in microbiology
researchProduct

Spectrum of pncA Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates Obtained in Latvia

2004

Pyrazinamide (PZA) is an effective antituberculous agent ([1][1]) that becomes active when bacterial pyrazinamidase converts it to pyrazinoic acid, which is toxic to mycobacteria ([4][2]). In Mycobacerium tuberculosis , PZA resistance is associated with the loss of pyrazinamidase activity, mainly

TuberculosisAntitubercular AgentsAmidohydrolasesMicrobiologyMycobacterium tuberculosischemistry.chemical_compoundPyrazinoic acidDrug Resistance Multiple BacterialmedicineHumansTuberculosisPharmacology (medical)Multidrug-Resistant Mycobacterium tuberculosisCodonLetters to the EditorPharmacologybiologyReverse Transcriptase Polymerase Chain ReactionMycobacterium tuberculosisPyrazinamidebiology.organism_classificationmedicine.diseaseLatviaPyrazinamideVirologyInfectious DiseaseschemistryMutationPncAmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia

2002

ABSTRACT To characterize the genetic basis of drug resistance in Mycobacterium tuberculosis in Latvia, mutations involved in rifampin ( rpoB gene) and isoniazid ( katG gene) resistance in DNA from 19 drug-susceptible and 51 multidrug-resistant M. tuberculosis complex isolates were analyzed. The most frequent rpoB gene mutations found by the Line Probe assay were the S531L (14 of 34 isolates), D516V (7 of 34), H526D (4 of 34), and D516Y plus P535S (4 of 34) mutations. Direct sequencing of seven isolates with unclear results from Line Probe assay showed the presence of the L533P mutation and the Q510H plus H526Y (1 of 34) and D516V plus P535S (4 of 34) double mutations, neither of which has b…

Microbiology (medical)Antitubercular AgentsMicrobial Sensitivity TestsDrug resistanceGene mutationmedicine.disease_causeMycobacterium tuberculosischemistry.chemical_compoundBacterial ProteinsDrug Resistance BacterialmedicineHumansTuberculosisGenePlant ProteinsGeneticsMutationbiologyMycobacteriology and Aerobic ActinomycetesDNA-Directed RNA PolymerasesMycobacterium tuberculosisbiology.organism_classificationrpoBLatviaMolecular biologyDrug Resistance MultiplePeroxidaseschemistryMutationRestriction fragment length polymorphismDNAJournal of Clinical Microbiology
researchProduct